The injection of a combination of broad-spectrum antibiotics (ampicillin, streptomycin and colistin), which eradicated the gut microbiome, compromised the effect of the anti-mouse PD-1 inhibitor and promoted tumour growth. This evidence concerns the gene PDCD1 and neoplasm.